CLINICAL_TRIALS
trial_result
· 2017-08-03
Clinical Trial Update: A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis [Phase 2]
Summary
Phase 2 dose-ranging study evaluating the safety and efficacy of the investigational compound GSK2586184 in patients with chronic plaque psoriasis; results have…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2017-08-03